sameAs
Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase geneThe C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1Collagen II containing a Cys substitution for Arg-alpha1-519: abnormal interactions of the mutated molecules with collagen IXPolymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance - preliminary results.Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.Targeted insertions of two exogenous collagen genes into both alleles of their endogenous loci in cultured human cells: the insertions are directed by relatively short fragments containing the promoters and the 5' ends of the genesComparison of cultures and 16S rRNA sequencing for identification of bacteria in two-stage revision arthroplasties: preliminary reportcDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components.Low Levels of HDL in Fragile X Syndrome PatientsTransfer of fibroblast sheets cultured on thermoresponsive dishes with membranes.CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescentsLiterature review concerning cell and skin substitute cultures obtained by means of tissue engineering used in the treatment of burns.Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.Novel bioactive polyester scaffolds prepared from unsaturated resins based on isosorbide and succinic acid.Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.Expression of the tumor suppressor gene hypermethylated in cancer 1 in laryngeal carcinoma.Creation of a system for the assembly and expression of DNA constructs encoding novel recombinant human procollagen II.Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080).The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy.Cytochrome P450 mRNA expressions along with in vitro differentiation of hepatocyte precursor cells from fetal, young and old rats.Expression and co-expression of surface markers of pluripotency on human amniotic cells cultured in different growth media.Optimization of genetic engineering and homologous recombination of collagen type I genes in rat bone marrow mesenchymal stem cells (MSC).Plasma Levels of Leptin and Adiponectin in Fragile X Syndrome.Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts.Anti-neuronal antibodies in patients with fragile X syndrome: is there a role of autoimmunity in its pathogenesis?Human procollagen type I surface-modified PHB-based non-woven textile scaffolds for cell growth: preparation and short-term biological tests.Controlling the Crystallinity of Thermoresponsive Poly(2-oxazoline)-Based Nanolayers to Cell Adhesion and Detachment.Poly(2-substituted-2-oxazoline) surfaces for dermal fibroblasts adhesion and detachment.Recombinant procollagen II: Deletion of D period segments identifies sequences that are required for helix stabilization and generates a temperature-sensitive N-proteinase cleavage site.Telomere length in elderly Caucasians weakly correlates with blood cell counts.Modified polyglycidol based nanolayers of switchable philicity and their interactions with skin cellsSynthesis and conformational properties of a recombinant C-propeptide of human type III procollagenFunctional and structural studies of tolloid-like 1 mutants associated with atrial-septal defect 6Heterogeneous Mixture of Amniotic Cells is Likely a Better Source of Stem Cells than Adipose TissueMultiple and terminal grafting of linear polyglycidol for surfaces of reduced protein adsorptionSite-specific interaction of bone morphogenetic protein 2 with procollagen IISurveyor nuclease detection of mutations and polymorphisms of mtDNA in childrenFrequency of the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene in patients with migraine with or without aura - a preliminary reportGene expression of extracellular matrix components in human amniotic cells - a pilot studyMutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III
P50
Q22010416-75C14118-43F6-454B-9A60-B6256DED33A8Q24599618-04F4FF7A-3909-4A21-821C-F41B2D8A4403Q28207769-C133E3B4-6971-452E-BD86-3552257A2B93Q34237989-7952F8C2-0278-40EF-965B-CC0DCD3EDB94Q34999946-FBD14FC2-C2E3-42EF-A59E-16F09F6A8040Q35631789-AFE80121-4C9C-4E5E-BE60-4F4E188D4A3BQ35970660-E9F3BEFA-8250-4935-93C1-0DBC9B9686E8Q36041851-E1C5EFE6-1130-4D77-9995-A6514BA18D76Q36526964-38156AF9-B529-4A84-9C0B-16A1421E39F7Q36879355-247B5B0B-5620-420E-9F16-2B81BDC93A23Q37104987-F5E69783-2EDD-40F8-850B-4FA4DF572939Q38225623-67722BA9-CC16-4FE7-B641-E40EBE3C82EEQ38703641-0C466181-8F06-447F-BF3E-563218872875Q38930451-F099ABA1-6A64-4365-875E-A2D979F45A26Q39099126-52B7BCD5-3551-46AE-92AD-BA93670ECEEBQ40774002-28385648-9758-4020-AC32-AA06FA49B50DQ41192569-9DC82127-99B6-4F30-9D40-723AED0656B9Q41487150-4B2D96B7-D580-4C87-B5A9-76B883D52A5DQ42831339-8A641A70-26E5-452F-BBB8-FE69D243A7CCQ43042201-E0857B14-530F-452C-B813-82A37EC86287Q44197022-7DDDE847-BD0F-4F12-8D7E-CBFF124AA939Q45160735-AB8BBA30-46CF-478B-B567-A53B57FE025BQ47864222-483D1D84-BE7C-4102-8C35-7344056AEB9DQ47956518-FBDEDB84-17B1-4164-BCFB-5E4BFF97BAB3Q50302371-9200B327-BEDA-4FD1-98F0-72515600CD14Q53400898-58BFE876-7C35-47B6-8742-CA5580227FD9Q53401376-2D36E542-9794-47FD-BD78-3367EBEBD914Q53644315-A0827529-94C6-4C31-9C12-54CE09E07A93Q54116080-428ED1FA-6A30-4E1A-8FCF-EDC0B9E5E2D6Q54335199-882925B2-118D-4FE2-8C22-3CB52D3C257EQ57352795-2a3b9957-4fc9-9d12-87b1-48db1e87581fQ57784014-6620F2A6-9669-47D6-B0E5-63291DF89350Q60915251-3C1F9678-CAF1-4C50-B560-0D43B65942B4Q64245234-9979A7F4-C39C-4E29-B218-E6CD71D38987Q67141909-8fab66f4-4436-aadd-a3bf-34d3aca00323Q74484057-EDF87FFE-60BA-4048-BEB9-10C22A1B7B10Q85174028-26C2FD3D-5969-44B4-A881-B3F084F70E6AQ85475876-1B264C15-D51D-4113-B30E-6612AEDA4ECEQ87676446-DF4BECCD-3E91-4965-9319-EE95447BD3BAQ88068802-31AC1B3A-C1FA-48BD-B07E-3074D29BED5A
P50
description
Polish internist, cardiologist
@en
cardioloog
@nl
dochtúir Polannach
@ga
polnischer Humanmediziner
@de
polski lekarz, internista, kardiolog, angiolog, balneolog
@pl
name
Aleksander Romuald Sieroń
@ast
Aleksander Romuald Sieroń
@es
Aleksander Romuald Sieroń
@nl
Aleksander Sieroń
@ca
Aleksander Sieroń
@cs
Aleksander Sieroń
@de
Aleksander Sieroń
@en
Aleksander Sieroń
@ga
Aleksander Sieroń
@gl
Aleksander Sieroń
@hr
type
label
Aleksander Romuald Sieroń
@ast
Aleksander Romuald Sieroń
@es
Aleksander Romuald Sieroń
@nl
Aleksander Sieroń
@ca
Aleksander Sieroń
@cs
Aleksander Sieroń
@de
Aleksander Sieroń
@en
Aleksander Sieroń
@ga
Aleksander Sieroń
@gl
Aleksander Sieroń
@hr
altLabel
Aleksander L Sieron
@ast
Aleksander L Sieron
@en
Aleksander L Sieron
@nl
Aleksander L Sieroń
@en
Aleksander Ludwik Sieroń
@en
Aleksander Ludwik Sieroń
@pl
Aleksander Romuald Sieroń
@en
Aleksander Romuald Sieroń
@pl
Aleksander Sieroń
@es
prefLabel
Aleksander Romuald Sieroń
@ast
Aleksander Romuald Sieroń
@es
Aleksander Romuald Sieroń
@nl
Aleksander Sieroń
@ca
Aleksander Sieroń
@cs
Aleksander Sieroń
@de
Aleksander Sieroń
@en
Aleksander Sieroń
@ga
Aleksander Sieroń
@gl
Aleksander Sieroń
@hr
P735
P214
P1053
G-1700-2013
P106
P1153
7006000297
P1207
P1412
P1559
Aleksander Sieroń
@pl
P21
P213
0000 0000 7178 8633
P214
P27
P31
P3124
P3829
P496
0000-0002-3894-9508
P569
1948-02-04T00:00:00Z
P7859
viaf-101905490